Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Q32 Bio (QTTB) EBT Margin (2018 - 2023)

Q32 Bio (QTTB) has 6 years of EBT Margin data on record, last reported at 573.25% in Q4 2023.

  • For Q4 2023, EBT Margin rose 469282.0% year-over-year to 573.25%; the TTM value through Sep 2024 reached 7.63%, up 66922.0%, while the annual FY2025 figure was 31.45%, N/A changed from the prior year.
  • EBT Margin reached 573.25% in Q4 2023 per QTTB's latest filing, up from 751.26% in the prior quarter.
  • Across five years, EBT Margin topped out at 11678.68% in Q1 2022 and bottomed at 8834.07% in Q1 2019.
  • Average EBT Margin over 5 years is 2732.97%, with a median of 3704.86% recorded in 2022.
  • Peak YoY movement for EBT Margin: skyrocketed 1168234bps in 2022, then crashed -1191071bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 4292.54% in 2019, then rose by 29bps to 3039.8% in 2020, then crashed by -38bps to 4187.41% in 2021, then grew by 2bps to 4119.58% in 2022, then soared by 114bps to 573.25% in 2023.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 573.25% in Q4 2023, 751.26% in Q3 2023, and 181.19% in Q2 2023.